General form of registration statement for all companies including face-amount certificate companies

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

v3.21.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Net Cash Provided by (Used in) Operating Activities        
NET LOSS $ (2,218,978) $ (2,542,978) $ (9,105,729) $ (11,510,166)
Adjustments to reconcile net loss to net cash used by operating activities:        
Amortization of Lease Liability 5,239 0    
Stock and warrants issued for services rendered - related party 0 297,247 2,302,044 759,378
Stock and warrants issued for services rendered 975,024 898,975 297,248 2,653,243
Warrants issued for Directors' Fees     1,248,615 192,614
Stocks and warrants issued for financing costs     0 165,432
Amortization of debt issuance costs     0 1,187,817
Amortization of bond discount     0 374,608
Amortization of lease liability     620 0
Changes in assets and liabilities:        
(Increase) in accounts receivable 0 (20,000)    
(Increase) in prepaid expenses (196,493) (125,592) (6,672) (666)
Increase in accounts payable 175,533 451,229 187,199 950,002
(Decrease) in Lease Liability (2,060) 0    
Increase in deferred revenue - participation agreements 55,201 0    
Increase in accrued liabilities and interest 154,537 258,051 654,460 1,520,441
(Increase) in security deposits     (3,000) 0
Increase in deferred revenue - participation agreements     1,836,800 0
Net Cash Provided by (Used in) Operating Activities (1,051,998) (783,068) (2,588,415) (3,707,297)
Cash Flows from Investing Activities:        
Net Cash From by Investing Activities 0 0 0 0
Net Cash Provided by (Used in) Financing Activities        
Proceeds from Loan Payable, related party - net of repayments 0 46,000    
Proceeds of Note Payable, other 190,500 0 20,000  
Payments of Note Payable, other (31,850) 0    
Deferred offering expenses (143,377) 0    
Proceeds from sale of common stock warrants - participation agreements 40,799 0    
Proceeds from exercise of common stock warrants 0 376,000    
Proceeds from sale of common stock - related party 50,000 0    
Proceeds from sales of common stock 1,040,000 25,000 400,866 2,650,000
Net Cash Provided by (Used in) Financing Activities 1,146,072 447,000 2,380,166 3,664,517
Proceeds from (payments of) loans payable, related parties     129,000 32,500
Proceeds of Loan Payable, other     121,700 0
Proceeds from sale of common stock warrants - participation agreements     898,200 0
Proceeds from exercise of common stock warrants     830,400 982,017
Increase (Decrease) in Cash 94,074 (336,068) (208,249) (42,780)
Cash and Cash Equivalents, at Carrying Value, Beginning Balance 137,862 346,111 346,111 388,891
Cash and Cash Equivalents, at Carrying Value, Ending Balance 231,935 10,043 137,862 346,111
Supplemental Cash Flow Information        
Interest Paid, Including Capitalized Interest, Operating and Investing Activities 514 0 0 0
Income Taxes Paid $ 0 $ 0 $ 0 $ 0